Stent Thrombosis after Endovascular Treatment of Iliofemoral or Caval Veins in Patients with Postthrombotic Syndrome

Andrea Cervi; James D. Douketis

doi:10.1055/s-0039-1700808

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2019; 119(12): 1897-1899
DOI: 10.1055/s-0039-1700808

Invited Editorial Focus

Georg Thieme Verlag KG Stuttgart · New York

Stent Thrombosis after Endovascular Treatment of Iliofemoral or Caval Veins in Patients with Postthrombotic Syndrome

Authors

Andrea Cervi

¹Department of Medicine, McMaster University, Hamilton, Ontario, Canada
James D. Douketis

¹Department of Medicine, McMaster University, Hamilton, Ontario, Canada

Abstract

Full Text

References

References
1 Kahn SR. How I treat postthrombotic syndrome. Blood 2009; 114 (21) 4624-4631
2 Rabinovich A, Kahn SR. How I treat the postthrombotic syndrome. Blood 2018; 131 (20) 2215-2222
3 Dronkers CEA, Mol GC, Maraziti G. , et al. Predicting post-thrombotic syndrome with ultrasonographic follow-up after deep vein thrombosis: a systematic review and meta-analysis. Thromb Haemost 2018; 118 (08) 1428-1438
4 Méan M, Limacher A, Alatri A, Aujesky D, Mazzolai L. Derivation and validation of a prediction model for risk stratification of post-thrombotic syndrome in elderly patients with a first deep vein thrombosis. Thromb Haemost 2018; 118 (08) 1419-1427
5 Amin EE, van Kuijk SMJ, Joore MA, Prandoni P, Ten Cate H, Ten Cate-Hoek AJ. Development and validation of a practical two-step prediction model and clinical risk score for post-thrombotic syndrome. Thromb Haemost 2018; 118 (07) 1242-1249
6 Haig Y, Enden T, Grøtta O. , et al; CaVenT Study Group. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol 2016; 3 (02) e64-e71
7 Vedantham S, Goldhaber SZ, Julian JA. , et al; ATTRACT Trial Investigators. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017; 377 (23) 2240-2252
8 Rabinovich A, Kahn SR. The postthrombotic syndrome: current evidence and future challenges. J Thromb Haemost 2017; 15 (02) 230-241
9 Razavi MK, Jaff MR, Miller LE. Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: systematic review and meta-analysis. Circ Cardiovasc Interv 2015; 8 (10) e002772
10 Qiu P, Zha B, Xu A. , et al. Systematic review and meta-analysis of iliofemoral stenting for post-thrombotic syndrome. Eur J Vasc Endovasc Surg 2019; 57 (03) 407-416
11 Sebastian T, Spirk D, Engelberger R. , et al. Incidence of stent thrombosis after endovascular treatment of iliofemoral or caval veins in patients with the postthrombotic syndrome. Thromb Haemost 2019; 119 (12) 2064-2073
12 Kearon C, Akl EA, Ornelas J. , et al. Antithrombotic therapy for VTE disease CHEST guideline and Expert Panel Report. Chest 2016; 149 (02) 315-352
13 Jaff MR, McMurtry MS, Archer SL. , et al; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123 (16) 1788-1830
14 Milinis K, Thapar A, Shalhoub J, Davies AH. Antithrombotic therapy following venous stenting: international Delphi consensus. Eur J Vasc Endovasc Surg 2018; 55 (04) 537-544